-
Symbol
-
ABOS on Nasdaq
-
Investment type
-
Equity / Common stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
3,417,075 shares
-
Security Ownership %
-
5.6%
Shares, Excluding Options vs Price
Sands Capital Alternatives, LLC ownership in Acumen Pharmaceuticals, Inc. Common stock, par value $0.0001 per share (ABOS)
13 Aug 2025 - Sands Capital Alternatives, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,417,075 shares of Acumen Pharmaceuticals, Inc. Common stock, par value $0.0001 per share (ABOS).
This represents 5.6% ownership of the company.
This is the first filing by Sands Capital Alternatives, LLC disclosing ownership of Acumen Pharmaceuticals, Inc. Common stock, par value $0.0001 per share (ABOS).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.